|
ACE/Angiotension receptors
Citations 551-560 of 992 total displayed.
|
Past content
(since Jan 1999):
|
- Editorial Commentaries
Targeting of the Renin-Angiotensin System as an Adjunct to Estrogen Replacement Therapy
- Lisa M. Harrison-Bernard
Hypertension 2004;44:390-391; published online before print as doi:10.1161/01.HYP.0000142894.20465.05
[Full text]
- Scientific Contributions
Ovariectomy Augments Hypertension in Aging Female Dahl Salt-Sensitive Rats
- Carmen Hinojosa-Laborde, Teresa Craig, Wei Zheng, Hong Ji, Joseph R. Haywood, and Kathryn Sandberg
Hypertension 2004;44:405-409; published online before print as doi:10.1161/01.HYP.0000142893.08655.96
[Abstract]
[Full text]
- Scientific Contributions
Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney
- Sérgio Veloso Brant Pinheiro, Ana Cristina Simões e Silva, Walkyria Oliveira Sampaio, Renata Dutra de Paula, Elizabeth Pereira Mendes, Elizabete Dias Bontempo, João Bosco Pesquero, Thomas Walther, Natalia Alenina, Michael Bader, Markus Bleich, and Robson Augusto Souza Santos
Hypertension 2004;44:490-496; published online before print as doi:10.1161/01.HYP.0000141438.64887.42
[Abstract]
[Full text]
- Brief Reviews
Pathophysiology of Hypertensive Renal Damage. Implications for Therapy
- Anil K. Bidani and Karen A. Griffin
Hypertension published September 27, 2004, doi:10.1161/01.HYP.0000145180.38707.84
[Abstract]
- Scientific Contributions
Fluvastatin Enhances the Inhibitory Effects of a Selective AT1 Receptor Blocker, Valsartan, on Atherosclerosis
- Zhen Li, Masaru Iwai, Lan Wu, Hong-Wei Liu, Rui Chen, Toyohisa Jinno, Jun Suzuki, Masahiro Tsuda, Xin-Yu Gao, Midori Okumura, Tai-Xing Cui, and Masatsugu Horiuchi
Hypertension published September 27, 2004, doi:10.1161/01.HYP.0000145179.44166.0f
[Abstract]
- Editorial Commentary
Peroxisome Proliferator-Activated Receptors Ligands, Oxidative Stress, and Cardiac Fibroblast Extracellular Matrix Turnover
- Francisco J. Villarreal and Juan Asbun
Hypertension published September 20, 2004, doi:10.1161/01.HYP.0000144401.18602.67
[Abstract]
- Scientific Contributions
NO Synthase Inhibition Increases Aldosterone in Humans
- James A.S. Muldowney, III, Stephen N. Davis, Douglas E. Vaughan, and Nancy J. Brown
Hypertension published September 20, 2004, doi:10.1161/01.HYP.0000143852.48258.f1
[Abstract]
- Scientific Contributions
Angiotensin-(1-7) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats
- Mariela M. Gironacci, María S. Valera, Irene Yujnovsky, and Clara Peña
Hypertension published September 20, 2004, doi:10.1161/01.HYP.0000143850.73831.9d
[Abstract]
- Editorial Commentaries
Hypertension: A Novel Regulator of Adaptive Immunity in Atherosclerosis?
- Alain Tedgui and Ziad Mallat
Hypertension 2004;44:257-258; published online before print as doi:10.1161/01.HYP.0000140270.26523.9b
[Full text]
- Scientific Contributions
Reduction of Vascular Noradrenaline Sensitivity by AT1 Antagonists Depends on Functional Sympathetic Innervation
- Walter Raasch, Peter Dominiak, Andreas Ziegler, and Andreas Dendorfer
Hypertension 2004;44:346-351; published online before print as doi:10.1161/01.HYP.0000138406.13413.0e
[Abstract]
[Full text]
|
|
